Original Research

Published on 27 Nov 2024

Hypoimmunogenic CD19 CAR-NK cells derived from embryonic stem cells suppress the progression of human B-cell malignancies in xenograft animals

in Cancer Immunity and Immunotherapy

Qi Zhang
Chengxiang Xia
Qitong Weng
Leqiang Zhang
Yao Wang
Yanhong Liu
Xiujuan Zheng
Yunqing Lin
Yi Chen
Yiyuan Shen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1504459

203 views

Original Research

Published on 27 Nov 2024

Atezolizumab plus bevacizumab and chemotherapy as first-line therapy for cervical cancer: a cost-effectiveness analysis in the US

in Cancer Immunity and Immunotherapy

Yingtao Lin
Cijuan Li
Chang Wang
Jian Chen
Yuanqing Huang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1481584

166 views

Original Research

Published on 27 Nov 2024

Checkpoint based immunotherapy in non-small cell lung cancer: a real-world retrospective study

in Cancer Immunity and Immunotherapy

Luigi Liguori
Gabriele Giorgio
Giovanna Polcaro
Valentina Pagliara
Domenico Malandrino
Francesco Perri
Marco Cascella
Alessandro Ottaiano
Valeria Conti
Alberto Servetto

Frontiers in Immunology

doi 10.3389/fimmu.2024.1419544

203 views

Review

Accepted on 26 Nov 2024

AKR1B10 and Digestive Tumours Development: A Review

in Cancer Immunity and Immunotherapy

Yao Shen
Ailin Qiu
Xing Huang
Xiaosha Wen
Sundar Ismail
Jian Zhang
Dixian Luo
Shenghui Yang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1462174

Case Report

Accepted on 26 Nov 2024

Case Report: Microsatellite instability-high pancreas adenosquamous carcinoma with postoperative liver metastasis recurrence treated with multimodality therapy achieving complete pathological response

in Cancer Immunity and Immunotherapy

Qinghua QingHua Liu
Ruoyun Li
Wei Zhu
Pengfei Zheng

Frontiers in Immunology

doi 10.3389/fimmu.2024.1456343

Original Research

Accepted on 26 Nov 2024

Pan-Cancer Analysis Shows That BCAP31 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types

in Cancer Immunity and Immunotherapy

Yangyong Sun
Zhi Li
Ying Xiao
Yaqiang Pan
Benbo LV
Xufeng Wang
Jianchao Liu
Zhiqiang Lin

Frontiers in Immunology

doi 10.3389/fimmu.2024.1507375

Original Research

Published on 26 Nov 2024

A novel molecular classification system based on the molecular feature score identifies patients sensitive to immune therapy and target therapy

in Cancer Immunity and Immunotherapy

Yang Li
Yinan Ding
Jinghao Wang
Xiaoxia Wu
Dinghu Zhang
Han Zhou
Pengfei Zhang
Guoliang Shao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1466069

380 views

Original Research

Published on 26 Nov 2024

Decoding NY-ESO-1 TCR T cells: transcriptomic insights reveal dual mechanisms of tumor targeting in a melanoma murine xenograft model

in Cancer Immunity and Immunotherapy

Alaa Alsalloum
Saleh Alrhmoun
Olga Perik-Zavosdkaia
Marina Fisher
Marina Volynets
Julia Lopatnikova
Roman Perik-Zavodskii
Julia Shevchenko
Julia Philippova
Olga Solovieva

Frontiers in Immunology

doi 10.3389/fimmu.2024.1507218

242 views

Original Research

Published on 26 Nov 2024

Research hotspots and trends in immunotherapy for cholangiocarcinoma: a bibliometric analysis (2014-2023)

in Cancer Immunity and Immunotherapy

Xilin Qu
Qian Wang
Fengfeng Zhu
Hao Liang
Zhangtao Long
Yachen Wu
Mengliang Jiang
Zhaohai Liu
Xiaoming Dai
Zhu Zhu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1436315

195 views

Case Report

Published on 26 Nov 2024

A surprising complete response to cadonilimab in a primary metastatic cervical cancer: a case report

in Cancer Immunity and Immunotherapy

Haijuan Yu
Jie Lin
Jian Chen
Lijun Chen
Jianping Zou
Bin Liu
Dan Hu
Youping Xiao
Linhao Yu
Yang Sun

Frontiers in Immunology

doi 10.3389/fimmu.2024.1494138

207 views

Clinical Trial

Published on 26 Nov 2024

Warehouse-based, immunopeptidome-guided design of personalised peptide vaccines shows feasibility in clinical trial evaluation in CLL patients

in Cancer Immunity and Immunotherapy

Jonas S. Heitmann
Susanne Jung
Marcel Wacker
Yacine Maringer
Annika Nelde
Jens Bauer
Monika Denk
Naomi Hoenisch-Gravel
Marion Richter
Melek T. Oezbek

Frontiers in Immunology

doi 10.3389/fimmu.2024.1482715

215 views

Original Research

Published on 26 Nov 2024

Exploring RPA1-ETAA1 axis via high-throughput data analysis: implications for PD-L1 nuclear translocation and tumor-immune dynamics in liver cancer

in Cancer Immunity and Immunotherapy

Gaofeng Qin
Zengkuan Chen
Weihong Tian
Hongbo Chen
Yu Zhang
Wangzhi Wei

Frontiers in Immunology

doi 10.3389/fimmu.2024.1492531

207 views

Review

Published on 26 Nov 2024

Traditional Chinese medicine and its components effectively reduce resistance mediated by immune checkpoint inhibitors

in Cancer Immunity and Immunotherapy

Mingxin Guo
Wentong Fang
Zhiqiang Hu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1429483

Original Research

Published on 26 Nov 2024

FOLFOX-HAIC combined with targeted immunotherapy for initially unresectable hepatocellular carcinoma: a real-world study

in Cancer Immunity and Immunotherapy

Yan-Cen Lu
Yu-Chen Yang
Di Ma
Jun-qing Wang
Feng-Jie Hao
Xu-xiao Chen
Yong-jun Chen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1471017

184 views

Original Research

Published on 26 Nov 2024

PRKDC regulates cGAMP to enhance immune response in lung cancer treatment

in Cancer Immunity and Immunotherapy

Zhanghao Huang
Runqi Huang
Jun Zhu
Youlang Zhou
Jiahai Shi

Frontiers in Immunology

doi 10.3389/fimmu.2024.1497570

118 views

Correction

Published on 26 Nov 2024

Corrigendum: Case report: A golden tail of immunotherapy: significant tail effect in a chemotherapy-resistant advanced pulmonary sarcomatoid carcinoma patient treated by Sintilimab combined with Anlotinib

in Cancer Immunity and Immunotherapy

Chenghao Fu
Haonan Du
Qiang Wang
Weiyou Zhu
Guangli Bian
Zhujuan Zhong
Yuheng Wang
Lei Cao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1527232

Navigation group

Articles

Hypoimmunogenic CD19 CAR-NK cells derived from embryonic stem cells suppress the progression of human B-cell malignancies in xenograft animals

Atezolizumab plus bevacizumab and chemotherapy as first-line therapy for cervical cancer: a cost-effectiveness analysis in the US

Checkpoint based immunotherapy in non-small cell lung cancer: a real-world retrospective study

AKR1B10 and Digestive Tumours Development: A Review

Case Report: Microsatellite instability-high pancreas adenosquamous carcinoma with postoperative liver metastasis recurrence treated with multimodality therapy achieving complete pathological response

Pan-Cancer Analysis Shows That BCAP31 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types

A novel molecular classification system based on the molecular feature score identifies patients sensitive to immune therapy and target therapy

Decoding NY-ESO-1 TCR T cells: transcriptomic insights reveal dual mechanisms of tumor targeting in a melanoma murine xenograft model

Research hotspots and trends in immunotherapy for cholangiocarcinoma: a bibliometric analysis (2014-2023)

A surprising complete response to cadonilimab in a primary metastatic cervical cancer: a case report

Warehouse-based, immunopeptidome-guided design of personalised peptide vaccines shows feasibility in clinical trial evaluation in CLL patients

Exploring RPA1-ETAA1 axis via high-throughput data analysis: implications for PD-L1 nuclear translocation and tumor-immune dynamics in liver cancer

Traditional Chinese medicine and its components effectively reduce resistance mediated by immune checkpoint inhibitors

FOLFOX-HAIC combined with targeted immunotherapy for initially unresectable hepatocellular carcinoma: a real-world study

PRKDC regulates cGAMP to enhance immune response in lung cancer treatment

Corrigendum: Case report: A golden tail of immunotherapy: significant tail effect in a chemotherapy-resistant advanced pulmonary sarcomatoid carcinoma patient treated by Sintilimab combined with Anlotinib